NASDAQ · Biotechnology

OSRH (OSRH) Stock

$0.43 +2.44% NASDAQ: OSRH Healthcare

Valuation

MetricValue
Price$0.43
Market Cap$10.64M
P/E Ratio12.81
P/B Ratio0.13
P/S Ratio3.59
EPS (TTM)$-4.02
52-Week High$1.71
52-Week Low$0.30
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-14.74%
ROA-6.88%
ROCE-14.17%
Gross Margin-70.05%
Operating Margin-7.26%
Net Margin-5.25%
Debt/Equity0.05
Current Ratio0.18

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$4.0M$3.0M
Operating Profit$0$0$-2.0M$-12.0M$-18.0M
Net Profit$0$0$0$-10.0M$-18.0M
EPS$0.00$0.00$0.07$-0.54$-4.02
Op Margin———-331.2%-631.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$0$37.0M$2.0M$171.0M
Total Liabilities$1.0M$0$4.0M$9.0M$44.0M
Cash$0$0$0$0$2.0M
Borrowings$0$0$0$3.0M$4.0M

Latest News

OSR Health, A Message From the CEO ACCESS Newswire · Jul 13, 2026 CORRECTION FROM SOURCE: Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target ACCESS Newswire · Jul 2, 2026 Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target ACCESS Newswire · Jul 2, 2026 OSR Health Announces Shareholder Loyalty Program to Reward Conviction Holders With Additional Shares ACCESS Newswire · Jun 25, 2026 OSR Holdings Is Now OSR Health - A New Name That Says Exactly What We Do ACCESS Newswire · Jun 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$-1.0M$-2.0M$-4.0M
Investing Cash Flow$0$0$-34.0M$36.0M$-3.0M
Financing Cash Flow$0$0$-28.0M$-36.0M$0
Net Cash Flow$0$0$0$0$1.0M
Free Cash Flow$0$0$-1.0M$-2.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-4.19
FCF Yield-57.63%
Quick Ratio0.14
Interest Coverage-18.00
Return 1Y-60.34%
Return 3Y-95.91%
Return 5Y—

Ownership

Insiders Held48.97%
Institutions Held0.83%
Institutions Float Held1.63%
Institutional HolderSharesReport Date
Geode Capital Management, LLC105,7432026-03-31
Xtx Topco Ltd60,7462026-03-31
Vanguard Capital Management LLC37,3732026-03-31
Toronto Dominion Bank40,0002026-03-31
Vanguard Fiduciary Trust Co17,0292026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About OSRH

OSRH is led by CEO Kuk Hyoun Hwang, employs 19 people, headquartered in US, publicly traded since 2023.

OSRH stock trades at $0.43 with a market capitalization of $10.64M. The stock is valued at a price-to-earnings (P/E) ratio of 12.81, price-to-book of 0.13, price-to-sales of 3.59. Over the past 52 weeks the stock has ranged between $0.30 and $1.71, and currently trades 74.9% below its 52-week high.

On profitability, OSRH generates a return on equity (ROE) of -14.74%, return on capital employed of -14.17%, an operating margin of -7.26%, a net profit margin of -5.25%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides